Oaktree Capital Group Holdings GP, LLC

Holdings History for BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Symbol: BTAI on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 170,230 shares
Security Ownership %: 2.7%

Oaktree Capital Holdings, LLC ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

15 May 2025 - Oaktree Capital Holdings, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 170,230 shares of BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI). This represents 2.7% ownership of the company. In their previous filing dated 18 Dec 2024, Oaktree Capital Group Holdings GP, LLC had reported owning 2,724,075 shares, indicating a decrease of +94%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Oaktree Capital Holdings, LLC	2.7%	-49%	$7,983,549	170,230	-2,553,845	-94%	$46.90	13G/A	31 Mar 2025	15 May 2025, 16:15
Oaktree Capital Group Holdings GP, LLC	5.2%		$127,755,304	2,724,075			$46.90	13G	25 Nov 2024	18 Dec 2024, 20:19